Aquaculture is the world’s emerging and growing food-producing
sector that meets the demand for animal protein for the worldwide
human population, which is expected to reach 9.7 billion by 2050. It
plays an essential role in providing over half of all fish for human
consumption and contributing to nutritional challenges, which is
crucial for global food security and nourishment. Cyprinus carpio is
one of the worldwide farmed fish species, due to its high consumer
acceptance and tolerance of a range of environmental conditions,
and has become a cornerstone in Asia, Central, and Eastern Europe.
The increased production of this species is economically beneficial,
mainly driven by the expansion of farming practices and intensive
aquaculture systems characterized by high stocking densities, which
produce chronic stressors on fish populations, elevating cortisol
levels, which improve growth rates and suppress immune function.
Many years ago, the aquaculture industry relied heavily on
prophylactic use of chemotherapeutics and antibiotics to control
diseases and improve efficiency. However, the consequences were
severe, as antimicrobial-resistant. Furthermore, the determination of
drugs in aquaculture carriages poses a risk to consumer safety, while
the release of these compounds into the environment disrupts
aquatic ecosystems. In response to these issues, stringent rules and
bans on the use of antibiotic growth promoters in animal feed have
been implemented in many countries, creating an urgent need for
safe, effective, and biologically sustainable substitutes. Sustainable
aquaculture has shifted to natural, plant-based additives, collectively
known as phytogenics or phytobiotics. These substances
demonstrated efficacy in enhancing growth performance and
enhancing nutrient digestibility. Many phytogenics possess effective
bioactive properties, such as antifungal, antioxidant, and anti
inflammatory activities, including Allium sativum, Curcuma longa, and
Xanthium strumarium L. These plants are regarded as natural
immunostimulants and respond efficiently to pathogen challenges,
thereby reducing disease prevalence of disease. Xanthium
strumarium L., widely known as the cocklebur shrub of the family
Asteraceae, is regarded as a harmful weed but is of importance in
Asia, America, and Africa due to a long history of use in traditional
medicine systems. Traditionally, it was used to treat illnesses such as
arthritis, tuberculosis, headache, and rhinitis due to its diverse
phytochemical constitution, presence of numerous bioactive
compounds which are potent pharmacological activities, and its
therapeutic potential. Aquaculture applications of X. strumarium
extracts have widely documented antioxidant properties,
hepatoprotective, and immunomodulatory. Furthermore, certain
fractions of the plant control immune responses, regulate cytokine
production, and stimulate lymphocyte proliferation. The increase in
the concentration of phenolic and flavonoid compounds alleviates
oxidative stress in rigorous farming conditions and reduces oxidative
damage, keeping cellular health, and gives the plant with significant
free-radical scavenging ability. X. strumarium, also known
fundamental principle in phytogenic feed additives with the biological
and beneficial effects, however, it is also recognized as a
carboxyatractyloside compound that causes hepatic necrosis at high
doses. Despite the significant research on its biochemical and
pharmacological properties, the use of X
See More
See Less